5:35 PM
 | 
Aug 20, 2014
 |  BC Extra  |  Company News

AZ, Mitsubishi Tanabe in diabetic nephropathy deal

AstraZeneca plc (LSE:AZN; NYSE:AZN) and Mitsubishi Tanabe Pharma Corp. (Tokyo:4508) partnered to validate and progress novel targets...

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >